Skip to main content

fosinopril

Generic: FOSINOPRIL SODIUM·Brand: FOSINOPRIL SODIUM, MONOPRIL

fosinopril: sourced relationships with 1 company · 1 FDA decision.

fosinopril evidence translation

What we can confirm

What it means

Source-backed records connect fosinopril to TEVA; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could fosinopril → TEVA affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Dated Pipeline Records (1)
CompanyDated record stage
Teva Pharmaceutical Industries Limited (TEVA)
Reported 2006-07-05 · Current development: unknownSource
Approved
FDA Decisions1 records
ApprovalINDICATIONS AND USAGE Fosinopril sodium tablets are indicated for the treatment of hypertension. They may be used alone or in combination with thiazide diuretics. Fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see DOSAGE AND ADMINISTRATION ). In using fosinopril sodium, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, c(TEVA)FDA ↗
ANDA076945OralTablet

Frequently asked questions

Which companies have sourced relationships with fosinopril?

fosinopril has dated SEC/FDA relationship records for Teva Pharmaceutical Industries Limited.

What is fosinopril's latest FDA decision?

The most recent tracked FDA decision for fosinopril is Approval for INDICATIONS AND USAGE Fosinopril sodium tablets are indicated for the treatment of hypertension. They may be used alone or in combination with thiazide diuretics. Fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see DOSAGE AND ADMINISTRATION ). In using fosinopril sodium, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, c, dated July 5, 2006.